{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:58:26Z","timestamp":1791388706675,"version":"4.3.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During early pregnancy, the maternal immune system recalibrates to tolerate the semi-allogeneic fetus. Immunoglobulin (Ig) function is modulated by glycosylation. Prior studies showed increases in anti-inflammatory glycosylation traits (galactosylation and sialylation) in IgG and to a lesser extent in IgA towards the third trimester. This study aimed to characterize IgG and IgA glycosylation patterns throughout pregnancy and assess associations with maternal age, gravidity, body mass index (BMI) and conception mode. In the Rotterdam Periconception Cohort, serum samples from 202 women with singleton pregnancies were collected at 9, 11, 13, 22, and 32\u00a0weeks'' gestation. IgG and IgA glycopeptides were analyzed using validated liquid chromatography\u2013mass spectrometry and summarized into galactosylation, sialylation, fucosylation, and bisection traits. Longitudinal changes were assessed with linear mixed-effects models and FDR correction and associations with maternal factors were derived from model estimates. Already in the first trimester, galactosylation and sialylation increased and bisection decreased for both IgG and IgA. IgG galactosylation and sialylation continued rising throughout pregnancy, whereas most IgA traits reversed after the first trimester. Higher BMI was associated with a pro-inflammatory profile (lower IgG galactosylation; higher IgG and IgA fucosylation). Assisted reproduction and nulliparity were associated with anti-inflammatory changes, including higher galactosylation and sialylation. In conclusion, IgG and IgA glycosylation shifts towards an anti-inflammatory profile as early as the first trimester, potentially promoting immune tolerance. Pro-inflammatory changes with higher BMI, and distinct profiles in nulliparous and ART pregnancies, may represent biological pathways linking maternal factors to pregnancy outcomes, supporting glycosylation as a candidate biomarker.<\/jats:p>\n                  <jats:p>Trial registration number: This study is registered at the Dutch Trial Register (NTR6854).<\/jats:p>","DOI":"10.1007\/s43032-026-02190-9","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:22:49Z","timestamp":1789662169000},"page":"2081-2093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Profiling of IgG and IgA Glycosylation in Pregnancy Reveals Early Associations with BMI, Nulliparity and Conception Mode: The Rotterdam Periconception Cohort"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0730-1928","authenticated-orcid":false,"given":"Lotte W.","family":"Voskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"Rousian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine P. M.","family":"Steegers-Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Verdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2190_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-immunol-032712-100003","volume":"31","author":"A Erlebacher","year":"2013","unstructured":"Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387\u2013411. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-100003.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2190_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2017.64","volume":"17","author":"G Mor","year":"2017","unstructured":"Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17(8):469\u201382. https:\/\/doi.org\/10.1038\/nri.2017.64.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2190_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/humupd\/dmt041","volume":"19","author":"RP Steegers-Theunissen","year":"2013","unstructured":"Steegers-Theunissen RP, Twigt J, Pestinger V, Sinclair KD. The periconceptional period, reproduction and long-term health of offspring: the importance of one-carbon metabolism. Hum Reprod Update. 2013;19(6):640\u201355. https:\/\/doi.org\/10.1093\/humupd\/dmt041.","journal-title":"Hum Reprod Update"},{"key":"2190_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","volume":"8","author":"CR Wilcox","year":"2017","unstructured":"Wilcox CR, Holder B, Jones CE. Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy. Front Immunol. 2017;8:1294. https:\/\/doi.org\/10.3389\/fimmu.2017.01294.","journal-title":"Front Immunol"},{"issue":"12","key":"2190_CR5","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/oxfordjournals.humrep.a135906","volume":"10","author":"E Jauniaux","year":"1995","unstructured":"Jauniaux E, Jurkovic D, Gulbis B, Liesnard C, Lees C, Campbell S. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum Reprod. 1995;10(12):3297\u2013300. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a135906.","journal-title":"Hum Reprod"},{"issue":"6","key":"2190_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/mi.2011.39","volume":"4","author":"JM Woof","year":"2011","unstructured":"Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol. 2011;4(6):590\u20137. https:\/\/doi.org\/10.1038\/mi.2011.39.","journal-title":"Mucosal Immunol"},{"issue":"5","key":"2190_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00281-021-00879-4","volume":"43","author":"C Seikrit","year":"2021","unstructured":"Seikrit C, Pabst O. The immune landscape of IgA induction in the gut. Semin Immunopathol. 2021;43(5):627\u201337. https:\/\/doi.org\/10.1007\/s00281-021-00879-4.","journal-title":"Semin Immunopathol"},{"key":"2190_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21\u201350. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141702.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2190_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/humupd\/dmad024","volume":"30","author":"J Zhong","year":"2024","unstructured":"Zhong J, Li J, Burton GJ, Koistinen H, Cheung KW, Ng EHY, et al. The functional roles of protein glycosylation in human maternal-fetal crosstalk. Hum Reprod Update. 2024;30(1):81\u2013108. https:\/\/doi.org\/10.1093\/humupd\/dmad024.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2190_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/glycob\/cwz065","volume":"30","author":"BA Cobb","year":"2020","unstructured":"Cobb BA. The history of IgG glycosylation and where we are now. Glycobiology. 2020;30(4):202\u201313. https:\/\/doi.org\/10.1093\/glycob\/cwz065.","journal-title":"Glycobiology"},{"key":"2190_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.Mam.2020.100891","volume":"79","author":"T \u0160tambuk","year":"2021","unstructured":"\u0160tambuk T, Klasi\u0107 M, Zoldo\u0161 V, Lauc G. N-glycans as functional effectors of genetic and epigenetic disease risk. Mol Aspects Med. 2021;79:100891-. https:\/\/doi.org\/10.1016\/j.Mam.2020.100891.","journal-title":"Mol Aspects Med"},{"key":"2190_CR12","doi-asserted-by":"publisher","unstructured":"Dekkers G, Treffers L, Plomp R, Bentlage AEH, Boer Md, Koeleman CAM, et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Frontiers in Immunology. 2017;8(AUG). https:\/\/doi.org\/10.3389\/fimmu.2017.00877.","DOI":"10.3389\/fimmu.2017.00877"},{"issue":"1","key":"2190_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imr.13407","volume":"328","author":"J Kristic","year":"2024","unstructured":"Kristic J, Lauc G. The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals. Immunol Rev. 2024;328(1):143\u201370. https:\/\/doi.org\/10.1111\/imr.13407.","journal-title":"Immunol Rev"},{"issue":"7","key":"2190_CR14","doi-asserted-by":"publisher","first-page":"e3685","DOI":"10.1002\/dmrr.3685","volume":"39","author":"E Memarian","year":"2023","unstructured":"Memarian E, Heijmans R, Slieker RC, Sierra A, Gornik O, Beulens JWJ, et al. IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes. Diabetes Metab Res Rev. 2023;39(7):e3685. https:\/\/doi.org\/10.1002\/dmrr.3685.","journal-title":"Diabetes Metab Res Rev"},{"key":"2190_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","volume":"333","author":"I Gudelj","year":"2018","unstructured":"Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65\u201379. https:\/\/doi.org\/10.1016\/j.cellimm.2018.07.009.","journal-title":"Cell Immunol"},{"issue":"4","key":"2190_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jprot.2011.11.003","volume":"75","author":"MH Selman","year":"2012","unstructured":"Selman MH, Derks RJ, Bondt A, Palmblad M, Schoenmaker B, Koeleman CA, et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J Proteomics. 2012;75(4):1318\u201329. https:\/\/doi.org\/10.1016\/j.jprot.2011.11.003.","journal-title":"J Proteomics"},{"issue":"11","key":"2190_CR17","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","volume":"13","author":"A Bondt","year":"2014","unstructured":"Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, et al. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014;13(11):3029\u201339. https:\/\/doi.org\/10.1074\/mcp.M114.039537.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"2190_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","volume":"178","author":"MF Jennewein","year":"2019","unstructured":"Jennewein MF, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette FJ, Krykbaeva M, et al. Fc glycan-mediated regulation of placental antibody transfer. Cell. 2019;178(1):202-15 e14. https:\/\/doi.org\/10.1016\/j.cell.2019.05.044.","journal-title":"Cell"},{"key":"2190_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep27955","volume":"6","author":"A Bondt","year":"2016","unstructured":"Bondt A, Nicolardi S, Jansen BC, Stavenhagen K, Blank D, Kammeijer GS, et al. Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides. Sci Rep. 2016;6:27955. https:\/\/doi.org\/10.1038\/srep27955.","journal-title":"Sci Rep"},{"issue":"1","key":"2190_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13075-017-1367-0","volume":"19","author":"A Bondt","year":"2017","unstructured":"Bondt A, Nicolardi S, Jansen BC, Kuijper TM, Hazes JMW, van der Burgt YEM, et al. IgA N- and O-glycosylation profiling reveals no association with the pregnancy-related improvement in rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):160. https:\/\/doi.org\/10.1186\/s13075-017-1367-0.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2190_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/pr401128j","volume":"13","author":"LR Ruhaak","year":"2014","unstructured":"Ruhaak LR, Uh HW, Deelder AM, Dolhain RE, Wuhrer M. Total plasma N-glycome changes during pregnancy. J Proteome Res. 2014;13(3):1657\u201368. https:\/\/doi.org\/10.1021\/pr401128j.","journal-title":"J Proteome Res"},{"issue":"6","key":"2190_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","volume":"63","author":"CW Redman","year":"2010","unstructured":"Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534\u201343. https:\/\/doi.org\/10.1111\/j.1600-0897.2010.00831.x.","journal-title":"Am J Reprod Immunol"},{"key":"2190_CR23","doi-asserted-by":"publisher","first-page":"575197","DOI":"10.3389\/fimmu.2020.575197","volume":"11","author":"B Abu-Raya","year":"2020","unstructured":"Abu-Raya B, Michalski C, Sadarangani M, Lavoie PM. Maternal immunological adaptation during normal pregnancy. Front Immunol. 2020;11:575197. https:\/\/doi.org\/10.3389\/fimmu.2020.575197.","journal-title":"Front Immunol"},{"issue":"5","key":"2190_CR24","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/ije\/dyab030","volume":"50","author":"M Rousian","year":"2021","unstructured":"Rousian M, Schoenmakers S, Eggink AJ, Gootjes DV, Koning AHJ, Koster MPH, et al. Cohort profile update: The Rotterdam Periconceptional Cohort and embryonic and fetal measurements using 3D ultrasound and virtual reality techniques. Int J Epidemiol. 2021;50(5):1426\u20137. https:\/\/doi.org\/10.1093\/ije\/dyab030.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"2190_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ije\/dyv147","volume":"45","author":"RPM Steegers-Theunissen","year":"2016","unstructured":"Steegers-Theunissen RPM, Verheijden-Paulissen JJFM, van Uitert EM, Wildhagen MF, Exalto N, Koning AHJ, et al. Cohort profile: The Rotterdam Periconceptional Cohort (predict study). Int J Epidemiol. 2016;45(2):374\u201381. https:\/\/doi.org\/10.1093\/ije\/dyv147.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2190_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bpobgyn.2009.01.011","volume":"23","author":"C Bottomley","year":"2009","unstructured":"Bottomley C, Bourne T. Dating and growth in the first trimester. Best Pract Res Clin Obstet Gynaecol. 2009;23(4):439\u201352. https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.01.011.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"2190_CR27","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1021\/acs.analchem.9b05722","volume":"92","author":"A Momcilovic","year":"2020","unstructured":"Momcilovic A, de Haan N, Hipgrave Ederveen AL, Bondt A, Koeleman CAM, Falck D, et al. Simultaneous immunoglobulin A and G glycopeptide profiling for high-throughput applications. Anal Chem. 2020;92(6):4518\u201326. https:\/\/doi.org\/10.1021\/acs.analchem.9b05722.","journal-title":"Anal Chem"},{"issue":"6","key":"2190_CR28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41596-024-00963-7","volume":"19","author":"D Falck","year":"2024","unstructured":"Falck D, Wuhrer M. GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout. Nat Protoc. 2024;19(6):1887\u2013909. https:\/\/doi.org\/10.1038\/s41596-024-00963-7.","journal-title":"Nat Protoc"},{"issue":"10","key":"2190_CR29","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1681\/ASN.2020081208","volume":"32","author":"V Dotz","year":"2021","unstructured":"Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, et al. O- and N-glycosylation of serum immunoglobulin A is associated with IgA nephropathy and glomerular function. J Am Soc Nephrol. 2021;32(10):2455\u201365. https:\/\/doi.org\/10.1681\/ASN.2020081208.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2190_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"4","key":"2190_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","volume":"17","author":"K Richani","year":"2005","unstructured":"Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17(4):239\u201345. https:\/\/doi.org\/10.1080\/14767050500072722.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2190_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052329","author":"H Baek","year":"2025","unstructured":"Baek H, Yang SW, Kim S, Lee Y, Park H, Park M, et al. Development of anti-inflammatory agents utilizing DC-SIGN mediated IL-10 secretion in autoimmune and immune-mediated disorders: bridging veterinary and human health. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26052329.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2190_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-020-14794-z","volume":"11","author":"A Garcia-Garcia","year":"2020","unstructured":"Garcia-Garcia A, Ceballos-Laita L, Serna S, Artschwager R, Reichardt NC, Corzana F, et al. Structural basis for substrate specificity and catalysis of alpha1,6-fucosyltransferase. Nat Commun. 2020;11(1):973. https:\/\/doi.org\/10.1038\/s41467-020-14794-z.","journal-title":"Nat Commun"},{"issue":"5","key":"2190_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/19420862.2018.1466767","volume":"10","author":"NA Pereira","year":"2018","unstructured":"Pereira NA, Chan KF, Lin PC, Song Z. The, \u201cless-is-more\u201d in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. MAbs. 2018;10(5):693\u2013711. https:\/\/doi.org\/10.1080\/19420862.2018.1466767.","journal-title":"MAbs"},{"key":"2190_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","volume":"12","author":"M Wuhrer","year":"2015","unstructured":"Wuhrer M, Selman MH, McDonnell LA, Kumpfel T, Derfuss T, Khademi M, et al. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J Neuroinflammation. 2015;12:235. https:\/\/doi.org\/10.1186\/s12974-015-0450-1.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2190_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10719-012-9381-6","volume":"30","author":"HK Einarsdottir","year":"2013","unstructured":"Einarsdottir HK, Selman MH, Kapur R, Scherjon S, Koeleman CA, Deelder AM, et al. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J. 2013;30(2):147\u201357. https:\/\/doi.org\/10.1007\/s10719-012-9381-6.","journal-title":"Glycoconj J"},{"issue":"6","key":"2190_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cmi.2014.46","volume":"11","author":"N Gomez-Lopez","year":"2014","unstructured":"Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M. Immune cells in term and preterm labor. Cell Mol Immunol. 2014;11(6):571\u201381. https:\/\/doi.org\/10.1038\/cmi.2014.46.","journal-title":"Cell Mol Immunol"},{"key":"2190_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2013.08.014","volume":"48","author":"M Nikolac Perkovic","year":"2014","unstructured":"Nikolac Perkovic M, Pucic Bakovic M, Kristic J, Novokmet M, Huffman JE, Vitart V, et al. The association between galactosylation of immunoglobulin G and body mass index. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:20\u20135. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.08.014.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2190_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14051626","author":"A Farkas","year":"2025","unstructured":"Farkas A, Suranyi A, Kolcsar B, Gyurkovits Z, Kozinszky Z, Vari SG, et al. Potential glycobiomarkers in maternal obesity and gestational diabetes during human pregnancy. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14051626.","journal-title":"J Clin Med"},{"issue":"1","key":"2190_CR40","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1038\/s41598-017-12495-0","volume":"7","author":"R Plomp","year":"2017","unstructured":"Plomp R, Ruhaak LR, Uh HW, Reiding KR, Selman M, Houwing-Duistermaat JJ, et al. Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci Rep. 2017;7(1):12325. https:\/\/doi.org\/10.1038\/s41598-017-12495-0.","journal-title":"Sci Rep"},{"key":"2190_CR41","doi-asserted-by":"publisher","first-page":"680227","DOI":"10.3389\/fimmu.2021.680227","volume":"12","author":"A Mijakovac","year":"2021","unstructured":"Mijakovac A, Juric J, Kohrt WM, Kristic J, Kifer D, Gavin KM, et al. Effects of estradiol on immunoglobulin G glycosylation: mapping of the downstream signaling mechanism. Front Immunol. 2021;12:680227. https:\/\/doi.org\/10.3389\/fimmu.2021.680227.","journal-title":"Front Immunol"},{"issue":"1","key":"2190_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","volume":"19","author":"T Kissel","year":"2023","unstructured":"Kissel T, Toes REM, Huizinga TWJ, Wuhrer M. Glycobiology of rheumatic diseases. Nat Rev Rheumatol. 2023;19(1):28\u201343. https:\/\/doi.org\/10.1038\/s41584-022-00867-4.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"2190_CR43","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2337\/dc22-0833","volume":"45","author":"A Birukov","year":"2022","unstructured":"Birukov A, Plavsa B, Eichelmann F, Kuxhaus O, Hoshi RA, Rudman N, et al. Immunoglobulin G N-glycosylation signatures in incident type 2 diabetes and cardiovascular disease. Diabetes Care. 2022;45(11):2729\u201336. https:\/\/doi.org\/10.2337\/dc22-0833.","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1007\/s43032-026-02227-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000}}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02190-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:45:14Z","timestamp":1791387914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02190-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02190-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s43032-026-02227-z","URL":"https:\/\/doi.org\/10.1007\/s43032-026-02227-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Rotterdam Periconception Cohort was approved by the Medical Ethics Review Committee of Erasmus MC University Medical Center (approval no. MEC-2004\u2013227).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants at enrollment into the cohort.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}